Spots Global Cancer Trial Database for tesetaxel
Every month we try and update this database with for tesetaxel cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC | NCT03952325 | Breast Cancer | Tesetaxel Tesetaxel Tesetaxel Nivolumab Pembrolizumab Atezolizumab Tesetaxel | 18 Years - | Odonate Therapeutics, Inc. | |
| Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer | NCT01573468 | Gastric Carcino... | Tesetaxel Placebo Capecitabine | 18 Years - | Genta Incorporated | |
| Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer | NCT01348009 | Gastric Carcino... | Tesetaxel-capec... | 20 Years - | Genta Incorporated | |
| Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer | NCT01609127 | Locally Advance... Metastatic Brea... | Tesetaxel Tesetaxel Capecitabine | 18 Years - | Genta Incorporated | |
| Study of Tesetaxel in Japanese Patients With Solid Tumors | NCT01337310 | Advanced Solid ... | Tesetaxel | 20 Years - | Genta Incorporated | |
| Phase II Study of Tesetaxel in Metastatic Melanoma | NCT01064713 | Advanced Melano... Cancer | Tesetaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Tesetaxel as First-line Therapy for Metastatic Breast Cancer | NCT01221870 | Breast Neoplasm | Tesetaxel once ... Tesetaxel once ... | 18 Years - | Genta Incorporated | |
| Tesetaxel for Previously Treated Patients With Bladder Cancer | NCT01215877 | Carcinoma, Tran... | Tesetaxel | 18 Years - | Genta Incorporated | |
| The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid Tumors | NCT04312282 | Advanced Solid ... | Tesetaxel Tesetaxel Itraconazole Rifampin | 18 Years - | Odonate Therapeutics, Inc. | |
| Phase II Study of Tesetaxel in Metastatic Melanoma | NCT01064713 | Advanced Melano... Cancer | Tesetaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer | NCT01095120 | Adenocarcinoma ... Adenocarcinoma ... | Tesetaxel | 18 Years - | Genta Incorporated | |
| Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC | NCT03952325 | Breast Cancer | Tesetaxel Tesetaxel Tesetaxel Nivolumab Pembrolizumab Atezolizumab Tesetaxel | 18 Years - | Odonate Therapeutics, Inc. | |
| Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH | NCT01092585 | Melanoma | Tesetaxel | 18 Years - | Genta Incorporated | |
| Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer | NCT01296243 | Prostate Cancer | Tesetaxel | 18 Years - | Genta Incorporated | |
| Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer | NCT01296243 | Prostate Cancer | Tesetaxel | 18 Years - | Genta Incorporated |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
